Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: Identification of N-methylnicotinamide and N-methyl-4-pyridone-3- carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography

Ringeissen, Stephanie, Connor, Susan C., Brown, H. Roger, Sweatman, Brian C., Hodson, Mark P., Kenny, Steve P., Haworth, Richard I., McGill, Paul, Price, Mark A., Aylott, Mike C., Nunez, Derek J., Haselden, John N. and Waterfield, Catherine J. (2003) Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: Identification of N-methylnicotinamide and N-methyl-4-pyridone-3- carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers, 8 3-4: 240-271. doi:10.1080/1354750031000149124


Author Ringeissen, Stephanie
Connor, Susan C.
Brown, H. Roger
Sweatman, Brian C.
Hodson, Mark P.
Kenny, Steve P.
Haworth, Richard I.
McGill, Paul
Price, Mark A.
Aylott, Mike C.
Nunez, Derek J.
Haselden, John N.
Waterfield, Catherine J.
Title Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: Identification of N-methylnicotinamide and N-methyl-4-pyridone-3- carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography
Formatted title
Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: Identification of N-methylnicotinamide and N-methyl-4-pyridone-3- carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography
Journal name Biomarkers   Check publisher's open access policy
ISSN 1354-750X
1366-5804
Publication date 2003-05
Sub-type Article (original research)
DOI 10.1080/1354750031000149124
Volume 8
Issue 3-4
Start page 240
End page 271
Total pages 32
Place of publication London, United Kingdom
Publisher Informa Healthcare
Language eng
Formatted abstract
This study identified two potential novel biomarkers of peroxisome proliferation in the rat. Three peroxisome proliferator-activated receptor (PPAR) ligands, chosen for their high selectivity towards the PPARα, -δ and -γ subtypes, were given to rats twice daily for 7 days at doses known to cause a pharmacological effect or peroxisome proliferation. Fenofibrate was used as a positive control. Daily treatment with the PPARα and -δ agonists produced peroxisome proliferation and liver hypertrophy. 1H nuclear magnetic resonance spectroscopy and multivariate statistical data analysis of urinary spectra from animals given the PPARα and -δ agonists identified two new potential biomarkers of peroxisome proliferation - N-methylnicotinamide (NMN) and N-methyl-4-pyridone-3-carboxamide (4PY) - both endproducts of the tryptophan-nicotinamide adenine dinucleotide (NAD+) pathway. After 7 days, excretion of NMN and 4PY increased 24- and three-fold, respectively, following high doses of fenofibrate. The correlation between total NMN excretion over 7 days and the peroxisome count was r=0.87 (r2=0.76). Plasma NMN, measured using a sensitive high performance liquid chromatography method, was increased up to 61-fold after 7 days' treatment with high doses of fenofibrate. Hepatic gene expression of aminocarboxymuconate-semialdehyde decarboxylase (EC 4.1.1.45) was downregulated following treatment with the PPARα and -δ agonists. The decrease was up to 11-fold compared with controls in the groups treated with high doses of fenofibrate. This supports the link between increased NMN and 4PY excretion and regulation of the tryptophan-NAD+ pathway in the liver. In conclusion, NMN, and possibly other metabolites in the pathway, are potential non-invasive surrogate biomarkers of peroxisome proliferation in the rat.
Keyword Biomarkers
N-methylnicotinamide
N-methyl-4-pyridone-3-carboxamide
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ
Additional Notes Journal issue May - August 2003

Document type: Journal Article
Sub-type: Article (original research)
Collection: Australian Institute for Bioengineering and Nanotechnology Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 54 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 58 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 03 Jun 2011, 14:26:18 EST by Dr Mark Hodson on behalf of Aust Institute for Bioengineering & Nanotechnology